TORONTO, April 08, 2021 (News) — Newscope Capital Corporation (the “Company”) (CSE: PHRM) (OTCQB: PHRRF) is pleased to announce that it has filed an alteration notice with BC Registry Services changing the name of the Company to PharmaTher Holdings Ltd. The name change was approved by the Company’s shareholders at the special meeting held on April 5, 2021. The Company will be filing the necessary documentation with the CSE in order to commence trading under its new name.
There is no change in the share capital of the Company or its trading symbol, and shareholders are not required to exchange their existing share certificates for new certificates.
About Newscope Capital Corporation
Newscope Capital Corporation is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat neuropsychiatric, neurodegenerative and pain disorders.
Learn more at: PharmaTher.com and follow us on Twitter and LinkedIn.
For more information, please contact:
Fabio Chianelli Chief Executive Officer Newscope Capital Corporation Tel: 1-888-846-3171 Email: email@example.com Website: www.pharmather.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
Business News Highlights
- Headline: Newscope Announces Name Change Canadian Stock Exchange:PHRM.CN
- Check all news and articles from the Business news updates.